As biopharma therapies become more sensitive, costly and complex, traditional compliance frameworks are no longer enough. Real-time visibility and IoT innovation are redefining what’s possible, and necessary, in temperature-controlled logistics.
Temperature control has always been a non-negotiable element in pharmaceutical logistics. But therapies have become more sensitive, routes are more complex and costs are sky-high, resulting in the biopharma industry losing around $35billion annually due to failures in temperature-controlled logistics.1 In this environment, compliance alone is no longer sufficient. Meeting the minimum standard does not guarantee the safety, efficacy, or timely delivery of life-saving treatments. And yet, many cold chain systems still rely on reactive monitoring and legacy infrastructure that can’t keep up with modern demands.
If the pharmaceutical industry wants to protect patients and products, it must reframe cold chain logistics as a strategic differentiator, not just a regulatory requirement. That starts with smarter, real-time visibility and IoT-driven resilience built for the realities of today’s pharma landscape.
